Literature DB >> 31545601

Understanding Interactions of Curcumin with Lipid Bilayers: A Coarse-Grained Molecular Dynamics Study.

Nazar Ileri Ercan1.   

Abstract

The interactions of curcumin with various lipid bilayers (POPC, DOPC, oxidized POPC, and oxidized DOPC) and model biomembranes (symmetric bacteria and yeast plasma membranes, as well as asymmetric mammalian plasma membrane) are investigated. A nonlinear thinning effect of curcumin with respect to its concentration is demonstrated in PC membranes and in the yeast. Curcumin induces asymmetry to the symmetric yeast membranes but reduces the degree of asymmetry of the mammalian plasma membranes when the molecule is placed facing the outer leaflets. The molecule is found to diffuse through oxidized PC bilayers, POPC bilayers at a curcumin to lipid ratio C/L = 1/5, yeast membranes at C/L = 1/100, and the mammalian plasma membranes at C/L = 1/5 and when the molecule placed facing the outer leaflets. The results of this work demonstrate that the lipid type, the lipid distribution, and curcumin amount play a critical role in defining the interactions of curcumin with the lipids and their transport behavior through the bilayers.

Entities:  

Year:  2019        PMID: 31545601     DOI: 10.1021/acs.jcim.9b00650

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  3 in total

1.  Fullerene translocation through peroxidized lipid membranes.

Authors:  Gulsah Gul; Nazar Ileri-Ercan
Journal:  RSC Adv       Date:  2021-02-15       Impact factor: 3.361

Review 2.  Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo Pharmacokinetics and Anticancer Pharmacodynamics.

Authors:  Mahsa Bagheri; Cornelus F van Nostrum; Robbert Jan Kok; Gert Storm; Wim E Hennink; Michal Heger
Journal:  Mol Pharm       Date:  2022-08-16       Impact factor: 5.364

3.  Curcumin activation of a bacterial mechanosensitive channel underlies its membrane permeability and adjuvant properties.

Authors:  Robin Wray; Irene Iscla; Paul Blount
Journal:  PLoS Pathog       Date:  2021-12-23       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.